Research Progress on the Multitarget Mechanisms of Terpenoids in the Treatment of Ischemic Stroke
Stroke Research and Treatment · 2026-01 · 2026 (1)
DOI: 10.1155/srat/4347247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke Research and Treatment, online erschienen am 31.07.2026. Verfasst von Jiao Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Massage, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Cerebral ischemic stroke (CIS) is an acute cerebrovascular disease associated with high morbidity and disability rates. It is characterized by neurological damage caused by the interruption of cerebral blood flow, often accompanied by sequelae such as motor dysfunction and cognitive decline, which seriously affect the quality of life of patients. Despite continuous advancements in treatment methods, challenges persist, such as time window constraints, limited efficacy, and potential adverse reactions. Therefore, finding more proactive and effective treatment approaches has become an urgent problem to be solved. The mechanism of action of terpenoids is not a simple single‐target inhibition. Essentially, it lies in the systematic remodeling of the postischemic neural microenvironment. The pathophysiological process of CIS involves complex cascades, including energy failure, excitotoxicity, oxidative stress, neuroinflammation, disruption of the blood–brain barrier, multiple cell death pathways, mitochondrial dysfunction, and impairment of nerve repair. Terpenoids can intervene in ischemic stroke through a dual‐mechanism approach of direct neuroprotection and indirect microenvironment regulation by targeting key nodes within the abovementioned pathological network, ultimately achieving the protection and restoration of neural function. The aim of this review was to deepen the understanding of the therapeutic value of terpenoids in stroke; from an integrated perspective, it revealed the scientific essence of the multitarget synergistic effects of natural products, thereby providing a theoretical cornerstone and an innovative direction for the development of next‐generation drugs for treating stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Acupuncture and Massage, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn.
- The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn.
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn.
- School of Nursing, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn.
ORCID-Profile: Jiao Yang, Zhifeng Wang, Ting Shi, Shiyuan Wu, Pengfen He, Yuxin Han, Daman Tian, Shuangfeng Xu, Junfeng Lan, Yujiang Xi, Jian Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Wang, Z., Shi, T., Wu, S., He, P., Han, Y., Tian, D., Xu, S., Lan, J., Xi, Y., Pan, P., & Wang, J. (2026). Research Progress on the Multitarget Mechanisms of Terpenoids in the Treatment of Ischemic Stroke. Stroke Research and Treatment, 2026(1). https://doi.org/10.1155/srat/4347247
Vancouver
Yang J, Wang Z, Shi T, Wu S, He P, Han Y, et al. Research Progress on the Multitarget Mechanisms of Terpenoids in the Treatment of Ischemic Stroke. Stroke Research and Treatment. 2026;2026(1). doi:10.1155/srat/4347247
BibTeX
@article{Yang2026,
author = {Yang, Jiao and Wang, Zhifeng and Shi, Ting and Wu, Shiyuan and He, Pengfen and Han, Yuxin and Tian, Daman and Xu, Shuangfeng and Lan, Junfeng and Xi, Yujiang and Pan, Pan and Wang, Jian},
title = {Research Progress on the Multitarget Mechanisms of Terpenoids in the Treatment of Ischemic Stroke},
journal = {Stroke Research and Treatment},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/srat/4347247}
}
EUVIMED